ArticleClinical case reports2024

Two-decade battle with myasthenia gravis: A breakthrough case report on the long-term success with eculizumab and ravulizumab treatment.

Stefan QuasthoffPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.